June
22
TriSalus Life Sciences Provides Update on Development of Immunotherapy Platform Approach for Liver and Pancreatic Tumors
PERIO-1 and PERIO-2 studies evaluating integration of SD-101 and PEDD administration DENVER and CHICAGO,...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.